Vir Biotechnology
VIR
VIR
233 hedge funds and large institutions have $605M invested in Vir Biotechnology in 2025 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 74 increasing their positions, 69 reducing their positions, and 26 closing their positions.
Holders
233
Holders Change
+26
Holders Change %
+12.56%
% of All Funds
3.17%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
54
Increased
74
Reduced
69
Closed
26
Calls
$1.87M
Puts
$1.81M
Net Calls
+$59K
Net Calls Change
-$5.68M
Top Buyers
Top Sellers
| 1 |
1
JPMorgan Chase & Co
New York
|
$2.85M |
| 2 |
2
Millennium Management
New York
|
$2.81M |
| 3 |
O
3
OrbiMed
New York
|
$14.6M |
| 4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$0 |
| 5 |
SCM
5
Sio Capital Management
New York
|
$3.07M |
